Extracellular HSP110 skews macrophage polarization in colorectal cancer

References

• Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-6; PMID:8484121; http://dx.doi.org/10.1126/science.8484121
   PubMed Web of Science ®Google Scholar
• Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363:558-61; PMID:8505985; http://dx.doi.org/10.1038/363558a0
   PubMed Web of Science ®Google Scholar
• Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260:816-9; PMID:8484122; http://dx.doi.org/10.1126/science.8484122
   PubMed Web of Science ®Google Scholar
• Collura A, Lagrange A, Svrcek M, Marisa L, Buhard O, Guilloux A, Wanherdrick K, Dorard C, Taieb A, Saget A et al. Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil-based chemotherapy. Gastroenterology 2014; 146:401-11 e1; PMID:24512910; http://dx.doi.org/10.1053/j.gastro.2013.10.054
   PubMed Web of Science ®Google Scholar
• Duval A, Collura A, Berthenet K, Lagrange A, Garrido C. Microsatellite instability in colorectal cancer: time to stop hiding! Oncotarget 2011; 2:826-7; PMID:22084152; http://dx.doi.org/10.18632/oncotarget.353
   PubMed Web of Science ®Google Scholar
• Dorard C, de Thonel A, Collura A, Marisa L, Svrcek M, Lagrange A, Jego G, Wanherdrick K, Joly AL, Buhard O et al. Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis. Nat Med 2011; 17:1283-9; PMID:21946539; http://dx.doi.org/10.1038/nm.2457
   PubMed Web of Science ®Google Scholar
• Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol 2013; 14:630-42; PMID:24026055; http://dx.doi.org/10.1038/nrm3658
   PubMed Web of Science ®Google Scholar
• Doyle SM, Genest O, Wickner S. Protein rescue from aggregates by powerful molecular chaperone machines. Nat Rev Mol Cell Biol 2013; 14:617-29; PMID:24061228; http://dx.doi.org/10.1038/nrm3660
   PubMed Web of Science ®Google Scholar
• Jego G, Hazoume A, Seigneuric R, Garrido C. Targeting heat shock proteins in cancer. Cancer Lett 2013; 332:275-85; PMID:21078542; http://dx.doi.org/10.1016/j.canlet.2010.10.014
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Arrigo AP, Calderwood SK. Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol 2013; 87:19-48; PMID:22885793; http://dx.doi.org/10.1007/s00204-012-0918-z
   PubMed Web of Science ®Google Scholar
• Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J et al. Significant overexpression of Hsp110 gene during colorectal cancer progression. Oncol Rep 2009; 21:1235-41; PMID:19360299; http://dx.doi.org/10.3892/or_00000346
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
   PubMed Web of Science ®Google Scholar
• Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976; http://dx.doi.org/10.1158/0008-5472.CAN-10-2907
   PubMed Web of Science ®Google Scholar
• Boissiere-Michot F, Lazennec G, Frugier H, Jarlier M, Roca L, Duffour J, Du Paty E, Laune D, Blanchard F, Le Pessot F et al. Characterization of an adaptive immune response in microsatellite-instable colorectal cancer. Oncoimmunology 2014; 3:e29256; PMID:25101223; http://dx.doi.org/10.4161/onci.29256
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41:14-20; PMID:25035950; http://dx.doi.org/10.1016/j.immuni.2014.06.008
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41:49-61; PMID:25035953; http://dx.doi.org/10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, Palmqvist R. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 2012; 7:e47045; PMID:23077543; http://dx.doi.org/10.1371/journal.pone.0047045
   PubMed Web of Science ®Google Scholar
• Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13:1472-9; PMID:17332291; http://dx.doi.org/10.1158/1078-0432.CCR-06-2073
   PubMed Web of Science ®Google Scholar
• Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010; 120:457-71; PMID:20093776; http://dx.doi.org/10.1172/JCI40483
   PubMed Web of Science ®Google Scholar
• Banerjee S, Lin CF, Skinner KA, Schiffhauer LM, Peacock J, Hicks DG, Redmond EM, Morrow D, Huston A, Shayne M et al. Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res 2011; 71:318-27; PMID:21224361; http://dx.doi.org/10.1158/0008-5472.CAN-10-1778
   PubMed Web of Science ®Google Scholar
• Laudanski K, De A, Miller-Graziano C. Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur J Immunol 2007; 37:2812-24; PMID:17823891; http://dx.doi.org/10.1002/eji.200636993
   PubMed Web of Science ®Google Scholar
• Qian J, Yi H, Guo C, Yu X, Zuo D, Chen X, Kane JM 3rd, Repasky EA, Subjeck JR, Wang XY. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma. J Immunol 2011; 187:2905-14; PMID:21832164; http://dx.doi.org/10.4049/jimmunol.1100703
   PubMed Web of Science ®Google Scholar
• Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol 2010; 11:19; PMID:20385003; http://dx.doi.org/10.1186/1471-2172-11-19
   PubMed Web of Science ®Google Scholar
• Banerjea A, Ahmed S, Hands RE, Huang F, Han X, Shaw PM, Feakins R, Bustin SA, Dorudi S. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer 2004; 3:21; PMID:15298707; http://dx.doi.org/10.1186/1476-4598-3-21
   PubMed Web of Science ®Google Scholar
• Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 2004; 91:469-75; PMID:15048750; http://dx.doi.org/10.1002/bjs.4472
   PubMed Web of Science ®Google Scholar
• Maby P, Tougeron D, Hamieh M, Mlecnik B, Kora H, Bindea G, Angell HK, Fredriksen T, Elie N, Fauquembergue E et al. Correlation between Density of CD8+ T-cell infiltrate in microsatellite unstable colorectal cancers and frameshift mutations: a rationale for personalized immunotherapy. Cancer Res 2015; 75:3446-55; PMID:26060019; http://dx.doi.org/10.1158/0008-5472.CAN-14-3051
   PubMed Web of Science ®Google Scholar
• Sherman M, Multhoff G. Heat shock proteins in cancer. Ann N Y Acad Sci 2007; 1113:192-201; PMID:17978282; http://dx.doi.org/10.1196/annals.1391.030
   PubMed Web of Science ®Google Scholar
• Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010; 2:238-47; PMID:20375559; http://dx.doi.org/10.1159/000296508
   PubMed Web of Science ®Google Scholar
• Asea A. Chaperokine-induced signal transduction pathways. Exerc Immunol Rev 2003; 9:25-33; PMID:14686091
   PubMed Web of Science ®Google Scholar
• Colgan SP, Pitman RS, Nagaishi T, Mizoguchi A, Mizoguchi E, Mayer LF, Shao L, Sartor RB, Subjeck JR, Blumberg RS. Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells. J Clin Invest 2003; 112:745-54; PMID:12952923; http://dx.doi.org/10.1172/JCI200317241
   PubMed Web of Science ®Google Scholar
• van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005; 5:318-30; PMID:15803151; http://dx.doi.org/10.1038/nri1593
   PubMed Web of Science ®Google Scholar
• Ferat-Osorio E, Sanchez-Anaya A, Gutierrez-Mendoza M, Bosco-Garate I, Wong-Baeza I, Pastelin-Palacios R, Pedraza-Alva G, Bonifaz LC, Cortés-Reynosa P, Pérez-Salazar E et al. Heat shock protein 70 down-regulates the production of toll-like receptor-induced pro-inflammatory cytokines by a heat shock factor-1/constitutive heat shock element-binding factor-dependent mechanism. J Inflamm (Lond) 2014; 11:19; PMID:25053922; http://dx.doi.org/10.1186/1476-9255-11-19
   PubMed Web of Science ®Google Scholar
• Stocki P, Dickinson AM. The immunosuppressive activity of heat shock protein 70. Autoimmune Dis 2012; 2012:617213; PMID:23326648; http://dx.doi.org/10.1155/2012/617213
   PubMedGoogle Scholar
• Stocki P, Wang XN, Dickinson AM. Inducible heat shock protein 70 reduces T cell responses and stimulatory capacity of monocyte-derived dendritic cells. J Biol Chem 2012; 287:12387-94; PMID:22334699; http://dx.doi.org/10.1074/jbc.M111.307579
   PubMed Web of Science ®Google Scholar
• Manjili MH, Park J, Facciponte JG, Subjeck JR. HSP110 induces “danger signals” upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology 2005; 210:295-303; PMID:16164037; http://dx.doi.org/10.1016/j.imbio.2005.04.002
   PubMed Web of Science ®Google Scholar
• Thuringer D, Jego G, Wettstein G, Terrier O, Cronier L, Yousfi N, Hébrard S, Bouchot A, Hazoumé A, Joly AL et al. Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3. Faseb J 2013; 27:4169-83; PMID:23804239; http://dx.doi.org/10.1096/fj.12-226977
   PubMed Web of Science ®Google Scholar
• Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007; 110:587-95; PMID:17395778; http://dx.doi.org/10.1182/blood-2007-01-068031
   PubMed Web of Science ®Google Scholar
• Mancino A, Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res 2010; 16:784-9; PMID:20103670; http://dx.doi.org/10.1158/1078-0432.CCR-09-1015
   PubMed Web of Science ®Google Scholar
• Fong CH, Bebien M, Didierlaurent A, Nebauer R, Hussell T, Broide D, Karin M, Lawrence T. An antiinflammatory role for IKKbeta through the inhibition of “classical” macrophage activation. J Exp Med 2008; 205:1269-76; PMID:18490491; http://dx.doi.org/10.1084/jem.20080124
   PubMed Web of Science ®Google Scholar
• Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, Göktuna SI, Neuenhahn M, Fierer J, Paxian S et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007; 130:918-31; PMID:17803913; http://dx.doi.org/10.1016/j.cell.2007.07.009
   PubMed Web of Science ®Google Scholar
• del Fresno C, Otero K, Gomez-Garcia L, Gonzalez-Leon MC, Soler-Ranger L, Fuentes-Prior P, Escoll P, Baos R, Caveda L, García F et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 2005; 174:3032-40; PMID:15728517; http://dx.doi.org/10.4049/jimmunol.174.5.3032
   PubMed Web of Science ®Google Scholar
• Facciponte JG, Wang XY, Subjeck JR. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. Eur J Immunol 2007; 37:2268-79; PMID:17615582; http://dx.doi.org/10.1002/eji.200737127
   PubMed Web of Science ®Google Scholar
• Broere F, van der Zee R, van Eden W. Heat shock proteins are no DAMPs, rather ‘DAMPERs’. Nat Rev Immunol 2011; 11:565; author reply; PMID:21785457; http://dx.doi.org/10.1038/nri2873-c1
   PubMed Web of Science ®Google Scholar
• Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov 2015; 5:43-51; PMID:25358689; http://dx.doi.org/10.1158/2159-8290.CD-14-0863
   PubMed Web of Science ®Google Scholar
• Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 2015; 372:2509-20; PMID:26028255; http://dx.doi.org/10.1056/NEJMoa1500596
   PubMed Web of Science ®Google Scholar
• Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008; 8:467-77; PMID:18500231; http://dx.doi.org/10.1038/nri2326
   PubMed Web of Science ®Google Scholar
• Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203:871-81; PMID:16606666; http://dx.doi.org/10.1084/jem.20050930
   PubMed Web of Science ®Google Scholar
• Wang XY, Subjeck JR. High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy. Int J Hyperthermia 2013; 29:364-75; PMID:23829534; http://dx.doi.org/10.3109/02656736.2013.803607
   PubMed Web of Science ®Google Scholar
• Mattoo RU, Sharma SK, Priya S, Finka A, Goloubinoff P. Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates. J Biol Chem 2013; 288:21399-411; PMID:23737532; http://dx.doi.org/10.1074/jbc.M113.479253
   PubMed Web of Science ®Google Scholar